Dennis Dean - 16 May 2024 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Reporting relationship: Chief Nonclinical Dev. Officer
Issuer ticker: THRD
Reported as of: 16 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 May 2024, 16:31:03 UTC
Next SEC filing: 17 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Christopher Murphy, Attorney-in-Fact

Key filing fact

Dennis Dean filed Form 4 for Third Harmonic Bio, Inc. (THRD) on 20 May 2024.

Key facts

This page summarizes Dennis Dean's Form 4 filing for Third Harmonic Bio, Inc. (THRD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 May 2024, 16:31.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THRD transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +210,000
Change %
Price: $0.000000
Shares after: 210,000
Date: 16 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 210,000
Exercise price: $14.23
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the total shares vest on May 16, 2025, and thereafter 2.08333% of the total shares underlying the award shall vest in equal monthly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.